REG - Optima Health PLC - Half Year Trading Update

Optima HealthAnnouncement

Yesterday 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251103:nRSC8641Fa&default-theme=true

RNS Number : 8641F  Optima Health PLC  03 November 2025

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment)
(EU Exit) Regulations 2019/310. Upon the publication of this announcement via
Regulatory Information Service, this inside information is now considered to
be in the public domain.

 

 

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

 

Half Year Trading Update

 

LONDON, UK, 3 November 2025, Optima Health (AIM: OPT), the UK's leading
provider of technology enabled corporate health and wellbeing solutions, today
announces its unaudited trading update ahead of publication of the Group's
results for the half year ended 30 September 2025 ("H1 26" or the "Period").

Highlights

 

·    Revenue for the Period of approximately £59 million; c.17% growth
over H1 25 (£50.8 million) and in line with market expectations

·    Robust balance sheet with net debt (excluding leases) of £4.7
million as at 30 September 2025

·    Mobilisation underway on £210 million contract to deliver medical
assessment services to UK Armed Forces

·  New business annualised wins of £1.9 million (H1 25: £3.6 million)
with a good pipeline of new potential opportunities

·    Irish acquisition of Cognate Health completed and successfully
rebranded as Optima Health Ireland

·    Acquisition of Care first Employee Assistance Business completed

·  Commenced programme to enhance our platform, further improving solutions
for our customers whilst improving our margins

 

Optima is pleased to report revenue for the half year of approximately £59
million (excluding approximately £2 million of Other Operating Income), in
line with market expectations representing c.17% growth versus H1 25. The
Group's unaudited net debt position (excluding leases) at 30 September 2025
was £4.7 million, comprised of a cash balance of £8.3 million, and £13
million of debt.

In line with the Group's strategy, Optima has made two strategic acquisitions
during H1 26 to further accelerate long-term growth and continue to increase
its market share, and broaden its capabilities, both in scope and geography.

 

Optima acquired Cognate Health Limited in Ireland for up to €9 million in
April 2025. As Optima's first international acquisition, the expansion is part
of the Group's broader growth strategy, positioning it to serve multinational
clients with operations in both the UK and Ireland. In September 2025, Cognate
was strategically rebranded as Optima Health Ireland allowing Optima to
demonstrate its capacity to seamlessly deliver occupational health services
across both the UK and Ireland.

 

In May 2025, Optima announced it had entered into an agreement to acquire Care
first, a leading provider of Employee Assistance Programmes from the Priory
Group for a net consideration of £15,000, which is expected to add c. £3.7
million of revenue per annum to the Group. Since completion of this
acquisition in June, progress has been made in the integration of this
business into the core Optima business.

 

The Group has commenced a programme to ensure our platform scales efficiently
for the next stage of our organic and inorganic growth. This programme will
include investments in technology in both clinical and operational delivery to
further improve and differentiate our solutions, with the objective to drive
organic growth through differentiated market leading solutions whilst reducing
our operating expenditure and improving our margins.

 

Optima expects to report its Interim Results for the six months ended 30
September 2025 in December 2025.

 

Jonathan Thomas, Chief Executive Officer of Optima Health, said: "We have
achieved solid progress in the first half of the year, in line with our
strategy, delivering growth year on year. The two strategic acquisitions that
we completed in the first half have strengthened our UK footprint and marked
our entry into our first international territory, expanding both our reach and
capability. Looking ahead, we are confident that the quality of our solutions
and platform, along with the targeted application of new technologies will
enable us to capture further market share and reinforce our position as the
UK's leading occupational health and wellbeing partner. Alongside this, we
will maintain our disciplined approach of identifying and executing value
enhancing M&A opportunities to accelerate growth. As mentioned at the full
year results, the Board continue to believe we are well positioned for growth
in FY 26."

 

 

 

Enquiries

 

 Optima Health                                       +44(0)3300085113

 Jonathan Thomas, CEO                                media@OptimaHealth.co.uk

 Heidi Giles, CFO

 Nominated Adviser and Corporate Broker

 Panmure Liberum Limited                             +44 (0)20 3100 2000

 Emma Earl / Will Goode / Mark Rogers

 Rupert Dearden

 UK Financial PR Adviser                             optimahealth@icrinc.com

 ICR Healthcare

 Mary-Jane Elliott / Angela Gray / Lindsey Neville

 

 

About Optima Health

 

Optima Health is the UK's leading provider of occupational health and
wellbeing services, delivering clinically led, technology-driven solutions to
organisations across the public and private sectors. With a team of more than
1,600 including 800 clinicians, Optima Health supports millions of employees
and operates from a network of more than 50 clinics nationwide.

 

In addition to its core UK market, Optima Health also operates in Ireland
under Optima Health Ireland, providing occupational health services to clients
nationwide.

 

For more information visit www.optimahealth.co.uk
(http://www.optimahealth.co.uk)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUUVRRVNUARUA



            Copyright 2019 Regulatory News Service, all rights reserved